1[1]Belch A,Kouroukis CT,Crump M,Sehn L.et al.A phase II study of bortezomib in mantle cell lymphoma:the National Cancer Institute of Canada Clinical Trials Group trial IND.150.Ann Oncol,2006,18(1):116.
2[2]Strauss SJ,Maharaj L,et al Bortezomib therapy in patients with relapsed or refractory lymphoma:potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity.J Clin Oncol,2006,24(13):2105-2112.
4[4]Vose JM,Link BK,et al Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated,aggressive non-Hodgkin's lymphoma.Leuk Lymphoma,2005,46(11):1569-1573.
